BioMed Research International / 2009 / Article / Tab 2

Research Article

Benefit of Whole Pelvic Radiotherapy Combined with Neoadjuvant Androgen Deprivation for the High-Risk Prostate Cancer

Table 2

Acute and late gastrointestinal and genitourinary side effects reported in study for high-risk patients ( ).

Side effectsWPRT + N-ADT (group A) PORT (group B)

Genitourinary acute
Grade 142 (60%)50 (55%).56
Grade 217 (25%)18 (21%)
Grade 32 (3%)3 (3%)
Gastrointestinal acute
Grade 150 (71%)48 (52%).32
Grade 225 (36%)41 (44%)
Grade 345 (64%)51 (56%)
Genitourinary late
Grade 119 (27%)38 (41%).088
Grade 251 (73%)54 (59%)
Grade 33 (%)3 (%)
Gastrointestinal late
Grade 151 (71%)69 (52%).32
Grade 25 (36%)5 (44%)
Grade 32 (%)3 (%)

WPRT: whole pelvic radiotherapy, PORT: prostate radiotherapy only.

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.